This inventor holds 2 USPTO granted patents and 10 published patent applications. Top assignee: Centessa Pharmaceuticals (UK) Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: William James Jonathan Finlay: Innovator in Antibody Development
Introduction
William James Jonathan Finlay is a prominent inventor based in Glasgow, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules. With a total of 2 patents to his name, Finlay is recognized for his innovative approaches to medical applications.
Latest Patents
Finlay's latest patents include groundbreaking work on CD47 binding agents. These patents provide antibody molecules that bind specifically to CD47, along with related nucleic acid molecules, vectors, and host cells. Additionally, the patents outline various medical uses for these antibody molecules. Another notable patent focuses on Anti C-MET antibodies, which also bind specifically to C-MET and include related nucleic acid molecules, vectors, and host cells, along with their medical applications.
Career Highlights
Finlay is currently associated with Centessa Pharmaceuticals (UK) Limited, where he continues to advance his research and development efforts. His work at Centessa Pharmaceuticals emphasizes the importance of innovative therapies in addressing complex medical challenges.
Conclusion
William James Jonathan Finlay is a key figure in the field of antibody development, with a focus on creating medical solutions through his patented inventions. His contributions are paving the way for advancements in biotechnology and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile